What is it about?
This study demonstrated the antiproliferative potential of several novel dehydroepiandrosterone derivatives, in prostate cancer cells.
Featured Image
Why is it important?
The three series of derivatives of dehydroepiandrosterone studied significantly decreased the number of viable metastatic prostate cancer cells, therefore showing therapeutic potential to treat metastatic prostate cancer.
Perspectives
These preclinical studies lay the foundation for developing new therapies that improve treatments for metastatic prostate cancer.
Dr Marisa Cabeza
Universidad Autónoma Metropolitana-Xochimilco
Read the Original
This page is a summary of: Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells, Oriental Journal Of Chemistry, June 2023, Oriental Scientific Publishing Company,
DOI: 10.13005/ojc/390301.
You can read the full text:
Contributors
The following have contributed to this page
